The estimated Net Worth of (Mauritius) Pte Ltd Cairnhi... is at least 136 百万$ dollars as of 7 May 2018. Cairnhi owns over 95,162 units of Portola Pharmaceuticals stock worth over 57,829,837$ and over the last 10 years sold PTLA stock worth over 78,529,987$.
has made over 62 trades of the Portola Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently sold 95,162 units of PTLA stock worth 622,359$ on 7 May 2018.
The largest trade 's ever made was selling 2,611,233 units of Portola Pharmaceuticals stock on 3 November 2016 worth over 2,323,997$. On average, trades about 530,605 units every 20 days since 2014. As of 7 May 2018 still owns at least 3,207,423 units of Portola Pharmaceuticals stock.
You can see the complete history of Cairnhi stock trades at the bottom of the page.
Over the last 16 years, insiders at Portola Pharmaceuticals have traded over 63,947,373$ worth of Portola Pharmaceuticals stock and bought 4,311,442 units worth 137,660,828$ . The most active insiders traders include (Mauritius) Pte Ltd Cairnhi...、James N Topper、Jeffrey W Bird. On average, Portola Pharmaceuticals executives and independent directors trade stock every 43 days with the average trade being worth of 1,543,350$. The most recent stock trade was executed by Hollings Renton on 1 November 2019, trading 5,000 units of PTLA stock currently worth 45,000$.
Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.
Portola Pharmaceuticals executives and other stock owners filed with the SEC include: